Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

13 Aug 2025 08:52

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeApax Global Alpha Limited
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Apax Global Alpha Limited
(d) Date dealing undertaken:12th August 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
OrdinaryPurchases227,279163.3162.6
OrdinarySales385,251163.4162.8

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th August 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
14th Sep 202011:24 amRNSDirector/PDMR Shareholding
10th Sep 202011:39 amRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNS2020 Interim Dividend
25th Aug 20207:00 amRNS2020 Interim Report and Accounts
25th Aug 20207:00 amRNS2020 Interim Results Highlights
17th Aug 20207:00 amRNSInitial Public Offering of Duck Creek
10th Aug 20209:28 amRNSDirector Declaration - Additional Directorship
22nd Jul 20207:01 amRNSApax Fund Valuation Comments
22nd Jul 20207:00 amRNSApax Funds’ Valuations as at 30 June 2020
25th Jun 20207:00 amRNS2020 AGA Investor Update
17th Jun 20205:26 pmRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSNotice of Interim Results
11th Jun 20205:03 pmRNSDirector Declaration - Additional Directorship
9th Jun 202010:04 amRNSNotice of Investor Update
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:02 pmRNSPrice Monitoring Extension
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
1st Jun 202012:08 pmRNSSecond Price Monitoring Extn
1st Jun 202012:02 pmRNSPrice Monitoring Extension
28th May 202012:07 pmRNSSecond Price Monitoring Extn
28th May 202012:02 pmRNSPrice Monitoring Extension
27th May 20202:46 pmRNSDirector/PDMR Shareholding
27th May 20202:45 pmRNSDirector/PDMR Shareholding
22nd May 202012:15 pmRNSDirector/PDMR Shareholding
20th May 20204:36 pmRNSDirector/PDMR Shareholding
18th May 20203:38 pmRNSDirector/PDMR Shareholding
15th May 20207:00 amRNSQuarterly results for 31 March 2020
14th May 20205:29 pmRNSDirector Declaration - Additional Directorship
13th May 20207:00 amRNSApax Funds’ Valuations as at 31 March 2020
29th Apr 202012:32 pmRNSResult of AGM
29th Apr 202011:41 amRNSDisclosure of rights attached to equity shares
21st Apr 20201:12 pmRNSAGM Update
20th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:42 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:07 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
14th Apr 202012:08 pmRNSSecond Price Monitoring Extn
14th Apr 202012:03 pmRNSPrice Monitoring Extension
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:35 pmRNSPrice Monitoring Extension
1st Apr 202012:08 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSAGM Update
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20201:13 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.